Correcting the record on BCG before we license new vaccines against tuberculosis
- PMID: 28949270
- PMCID: PMC5728619
- DOI: 10.1177/0141076817732965
Correcting the record on BCG before we license new vaccines against tuberculosis
Similar articles
-
Tuberculosis vaccines: beyond bacille Calmette-Guerin.Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2782-9. doi: 10.1098/rstb.2011.0097. Philos Trans R Soc Lond B Biol Sci. 2011. PMID: 21893541 Free PMC article. Review.
-
Modern vaccines. Mycobacterial diseases.Lancet. 1990 Apr 28;335(8696):1016-20. doi: 10.1016/0140-6736(90)91074-k. Lancet. 1990. PMID: 1970071 Review. No abstract available.
-
Immunity to mycobacteria with emphasis on tuberculosis: implications for rational design of an effective tuberculosis vaccine.Chem Immunol. 1998;70:21-59. doi: 10.1159/000058699. Chem Immunol. 1998. PMID: 9509669 Review. No abstract available.
-
Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.Immunology. 2014 Oct;143(2):277-86. doi: 10.1111/imm.12308. Immunology. 2014. PMID: 24773322 Free PMC article.
-
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.Lancet Respir Med. 2019 Sep;7(9):757-770. doi: 10.1016/S2213-2600(19)30251-6. Epub 2019 Aug 12. Lancet Respir Med. 2019. PMID: 31416768 Clinical Trial.
Cited by
-
Current trends in tuberculosis vaccine.Med J Armed Forces India. 2019 Jan;75(1):18-24. doi: 10.1016/j.mjafi.2018.12.013. Epub 2019 Jan 18. Med J Armed Forces India. 2019. PMID: 30705473 Free PMC article. Review.
-
Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.J Infect Dis. 2019 Aug 30;220(7):1091-1098. doi: 10.1093/infdis/jiz285. J Infect Dis. 2019. PMID: 31165861 Free PMC article. Review.
-
Attenuated tuberculin skin test responses associated with Mycobacterium intracellulare sputum colonization in an adolescent TB prevalence survey in Western Kenya.Tuberculosis (Edinb). 2024 Jul;147:102514. doi: 10.1016/j.tube.2024.102514. Epub 2024 May 5. Tuberculosis (Edinb). 2024. PMID: 38723342 Free PMC article.
-
A welcome return to lectures in JRSM.J R Soc Med. 2017 Nov;110(11):423. doi: 10.1177/0141076817741236. J R Soc Med. 2017. PMID: 29148871 Free PMC article. No abstract available.
-
Humoral correlate of vaccine-mediated protection from tuberculosis identified in humans and non-human primates.bioRxiv [Preprint]. 2024 Dec 9:2024.12.05.627012. doi: 10.1101/2024.12.05.627012. bioRxiv. 2024. PMID: 39713388 Free PMC article. Preprint.
References
-
- Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013; 34: 271–286. - PubMed
-
- Kaufmann SH, Weiner J, von Reyn CF. Novel approaches to tuberculosis vaccine development. Int J Infect Dis 2017; 56: 263–267. - PubMed
-
- Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994; 271: 698–702. - PubMed
-
- Clemens JD, Chuong JJ, Feinstein AR. The BCG controversy: a methodological and statistical reappraisal. JAMA 1983; 249: 2362–2369. - PubMed
-
- Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58: 470–480. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical